Hydrochloric Acid → 1-(4-(2'-Chloro-5-methoxy-[1,1'-biphenyl]-3-carbonyl)piperazin-1-yl)prop-2-en-1-one
반응식
[C:1]([N:5]1[CH2:10][CH2:9][N:8]([C:11]([O:13]C(C)(C)C)=O)[CH2:7][CH2:6]1)(=[O:4])[CH:2]=[CH2:3].Cl.CO.[Cl:21][C:22]1[CH:27]=[CH:26][CH:25]=[CH:24][C:23]=1[C:28]1[CH:29]=[C:30]([CH:34]=[C:35]([O:37][CH3:38])[CH:36]=1)C(O)=O.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.CCN(CC)CC>C(Cl)Cl.CN(C=O)C>[Cl:21][C:22]1[CH:27]=[CH:26][CH:25]=[CH:24][C:23]=1[C:28]1[CH:36]=[C:35]([O:37][CH3:38])[CH:34]=[C:30]([C:11]([N:8]2[CH2:7][CH2:6][N:5]([C:1](=[O:4])[CH:2]=[CH2:3])[CH2:10][CH2:9]2)=[O:13])[CH:29]=1참가 물질
반응물 7
생성물 1
시약·촉매·용매 2
실험 절차
To a solution of tert-butyl 4-acryloylpiperazine-1-carboxylate (260 mg, 1.07 mmol) in DCM (2 mL), a solution of HCl in MeOH (10 mL, 28.6 mmol) was added and the resulting mixture was stirred at room temperature for 1 h. The mixture was concentrated in vacuo. The residue was added to the solution of 3-(2-chlorophenyl)-5-methoxybenzoic acid (280 mg, 1.07 mmol), HOBt (290 mg, 2.17 mmol), EDCI.HCl (410 mg, 2.17 mmol) and Et3N (324 mg, 3.21 mmol) in DMF (10 mL). The resulting mixture was stirred at room temperature for 16 h and partitioned between DCM and saturated NaHCO3 solution. The organic layer was dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (dichloromethane/methanol=50:1) to afford the desired product (200 mg, 52% yield). ESI-MS m/z: 385.2[M+H]+.
후처리
- concentrationThe mixture was concentrated in vacuo
- stirringThe resulting mixture was stirred at room temperature for 16 h
- custompartitioned between DCM and saturated NaHCO3 solution
- dry with materialThe organic layer was dried over MgSO4
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue was purified by flash column chromatography on silica gel (dichloromethane/methanol=50:1)
출처 및 근거
- ORD 기록
- ord-7285c600060044cd938c36ed92417e48
- 출처 데이터셋
- uspto-grants-2016_01
- 특허 번호
- US09227978B2
반응 노트
불러오는 중…